Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Catalyst Pharmaceuticals (CPRX) over the last 4 years, with Q4 2024 value amounting to $364861.0.

  • Catalyst Pharmaceuticals' Gains from Sales and Divestitures changed N/A to $364861.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $364861.0, marking a year-over-year change of. This contributed to the annual value of $364861.0 for FY2024, which is N/A changed from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Gains from Sales and Divestitures stood at $364861.0 for Q4 2024.
  • In the past 5 years, Catalyst Pharmaceuticals' Gains from Sales and Divestitures registered a high of $364861.0 during Q4 2024, and its lowest value of $364861.0 during Q4 2024.